Analyst firms · Needham · ZBH

Needham ZBH price target and rating history

Zimmer Biomet Holdings Inc. (ZBH) · Health Care

Needham rates Zimmer Biomet Holdings Inc. (ZBH) Hold with a $143 price target, as of its latest action on May 27, 2022. It has published 4 rating actions on ZBH since December 2021, including 0 upgrades and 2 downgrades. Across 6 firms with a ZBH price target in the last 12 months, the median target is $100.

Current rating

Hold

Price target

$143

Median target, all firms

$100

Actions on ZBH

4

Needham price target on ZBH

Every Needham rating on ZBH

• May 27, 2022
  DowngradeNeedham downgrades to Hold from Buy
• Feb 8, 2022
  ReiterateNeedham cuts its price target to $143 from $155, keeps Buy
• Jan 21, 2022
  ReiterateNeedham cuts its price target to $155 from $158, keeps Buy
• Dec 9, 2021
  DowngradeNeedham downgrades to Buy from Strong Buy, price target $175 to $158

How other firms rate ZBH

Each firm's latest rating and stated target in the last 12 months.

Questions about Needham and ZBH

What is Needham's price target for ZBH?

Needham's latest stated price target for Zimmer Biomet Holdings Inc. (ZBH) is $143, from its action on Feb 8, 2022.

What is Needham's rating on ZBH?

Needham rates ZBH Hold, a neutral rating, as of May 27, 2022.

When did Needham last change its view on ZBH?

On May 27, 2022, Needham downgrades to Hold from Buy.

How does Needham's ZBH target compare with other analysts?

Across 6 firms with a ZBH price target in the last 12 months, the median target is $100.

More ZBH rating histories

• Barclays3
• UBS4
• BTIG3
• Raymond James3
• Evercore ISI4
• Piper Sandler3
• Jefferies3
• RBC Capital Markets3
• Wells Fargo3
• Truist Securities3
• Loop Capital3

All Needham ratingsZBH news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.